Tigecycline is indicated for complicated intra-abdominal and skin infections caused by multidrug-resistant organisms (ESBL, MRSA). It provides very broad-spectrum coverage, including anaerobes, making it highly valuable when options are limited. Ideal for critically ill patients with resistant infections.